Receptor News and Research

RSS
Multifunctional RNA nanoparticles could overcome treatment resistance in breast cancer, study shows

Multifunctional RNA nanoparticles could overcome treatment resistance in breast cancer, study shows

New duo therapy offers hope for 'super blockage' of over-active immune system

New duo therapy offers hope for 'super blockage' of over-active immune system

One fifth of breast cancer patients do not complete their prescribed endocrine therapy

One fifth of breast cancer patients do not complete their prescribed endocrine therapy

UNMC seeking patients with lymphoma to evaluate two-drug oral therapy

UNMC seeking patients with lymphoma to evaluate two-drug oral therapy

Depression drug can alleviate joint pain in postmenopausal women treated for breast cancer

Depression drug can alleviate joint pain in postmenopausal women treated for breast cancer

Controversial hormone could fight against recurring breast cancers

Controversial hormone could fight against recurring breast cancers

Enzyme that cleaves beta carotene may control testosterone levels

Enzyme that cleaves beta carotene may control testosterone levels

Biochemists uncover how potential diabetes drugs interact with LRH-1 protein

Biochemists uncover how potential diabetes drugs interact with LRH-1 protein

Researchers unveil new role of thymic dendritic cells in controlling T lymphocyte egress into the blood

Researchers unveil new role of thymic dendritic cells in controlling T lymphocyte egress into the blood

Researchers find strong link between angiotensin receptor autoantibodies and increased risk of frailty

Researchers find strong link between angiotensin receptor autoantibodies and increased risk of frailty

Experimental T-cell therapy shows promise in preventing AML relapse

Experimental T-cell therapy shows promise in preventing AML relapse

Scientists identify potential dual-acting therapeutic strategy for aggressive form of breast cancer

Scientists identify potential dual-acting therapeutic strategy for aggressive form of breast cancer

Auditory deficits in people with schizophrenia linked to dysfunctional brain receptors

Auditory deficits in people with schizophrenia linked to dysfunctional brain receptors

Researchers receive Stafford Fox Medical Research Foundation grant to accelerate CFS diagnosis

Researchers receive Stafford Fox Medical Research Foundation grant to accelerate CFS diagnosis

Monell Center receives Gates Foundation grant to support innovative global health research project

Monell Center receives Gates Foundation grant to support innovative global health research project

Cluster signaling mechanism causes T cells to turn pathogenic in multiple sclerosis, research shows

Cluster signaling mechanism causes T cells to turn pathogenic in multiple sclerosis, research shows

TSRI scientists discover potential drug candidate to suppress pain and itch

TSRI scientists discover potential drug candidate to suppress pain and itch

Combination treatment may be valuable therapeutic option for HER2-negative metastatic breast cancer

Combination treatment may be valuable therapeutic option for HER2-negative metastatic breast cancer

Novel imaging technique shows promise to detect, monitor and guide therapy for prostate cancer

Novel imaging technique shows promise to detect, monitor and guide therapy for prostate cancer

Scientists identify cell-surface receptor for progranulin

Scientists identify cell-surface receptor for progranulin

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.